These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33645271)

  • 1. Anal cancer survival: a socioeconomic analysis.
    Ali F; Ghareeb AE; Jha A; Van der Voet H; Garg D; Jha M
    Ann R Coll Surg Engl; 2021 Mar; 103(3):191-196. PubMed ID: 33645271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Survival of Patients With Anal Adenocarcinoma, Squamous Cell Carcinoma of the Anus, and Rectal Adenocarcinoma.
    Franklin RA; Giri S; Valasareddy P; Lands LT; Martin MG
    Clin Colorectal Cancer; 2016 Mar; 15(1):47-53. PubMed ID: 26362848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoradiotherapy for squamous cell anal carcinoma: a review of prognostic factors.
    Kapacee ZA; Susnerwala S; Wise M; Biswas A; Danwata F; Scott N
    Colorectal Dis; 2016 Nov; 18(11):1080-1086. PubMed ID: 27028038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insurance status and level of education predict disparities in receipt of treatment and survival for anal squamous cell carcinoma.
    Patel KS; Alhatem A; Gadde U; Ahlawat S; Lambert C; Schwartz RA; Dalla Piazza M
    Cancer Epidemiol; 2020 Aug; 67():101723. PubMed ID: 32408241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of serum CYFRA 21-1 1 in patients with anal canal squamous cell carcinoma treated with radio(chemo)therapy.
    Gauthé M; Richard-Molard M; Rigault E; Buecher B; Mariani P; Bellet D; Cacheux W; Lièvre A
    BMC Cancer; 2018 Apr; 18(1):417. PubMed ID: 29653564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of Care and Comparison of Outcomes Between Primary Anal Squamous Cell Carcinoma and Anal Adenocarcinoma.
    Malakhov N; Kavi AM; Lee A; Adedoyin P; Sheth N; Lederman AJ; Schreiber D
    Dis Colon Rectum; 2019 Dec; 62(12):1448-1457. PubMed ID: 31725581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicity and survival of anal cancer patients treated with intensity-modulated radiation therapy.
    Ghareeb A; Paramasevon K; Mokool P; van der Voet H; Jha M
    Ann R Coll Surg Engl; 2019 Mar; 101(3):168-175. PubMed ID: 30482037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns and Predictors of Relapse Following Radical Chemoradiation Therapy Delivered Using Intensity Modulated Radiation Therapy With a Simultaneous Integrated Boost in Anal Squamous Cell Carcinoma.
    Shakir R; Adams R; Cooper R; Downing A; Geh I; Gilbert D; Jacobs C; Jones C; Lorimer C; Namelo WC; Sebag-Montefiore D; Shaw P; Muirhead R
    Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):329-339. PubMed ID: 31629837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of socioeconomic status on survival for patients with anal cancer.
    Lin D; Gold HT; Schreiber D; Leichman LP; Sherman SE; Becker DJ
    Cancer; 2018 Apr; 124(8):1791-1797. PubMed ID: 29527660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes of definitive radiation with volumetric modulated arc therapy and concurrent chemotherapy for squamous cell carcinoma of the anus in a regional Australian cancer centre.
    Hsieh MT; Shakespeare TP; Winkley L; Goonetilleke D; Yap SZL; Tahir ARM
    J Med Imaging Radiat Oncol; 2024 Apr; 68(3):325-332. PubMed ID: 38450897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil:lymphocyte ratio as a simple and novel biomarker for prediction of locoregional recurrence after chemoradiotherapy for squamous cell carcinoma of the anus.
    Toh E; Wilson J; Sebag-Montefiore D; Botterill I
    Colorectal Dis; 2014 Mar; 16(3):O90-7. PubMed ID: 24148256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of tobacco smoking on the patient's outcome after (chemo)radiotherapy for anal cancer.
    Lerman J; Hennequin C; Etienney I; Abramowitz L; Goujon G; Gornet JM; Guillerm S; Aparicio T; Valverde A; Cattan P; Quéro L
    Eur J Cancer; 2020 Dec; 141():143-151. PubMed ID: 33137590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensity-modulated radiotherapy improves survival and reduces treatment time in squamous cell carcinoma of the anus: A National Cancer Data Base study.
    Elson JK; Kachnic LA; Kharofa JR
    Cancer; 2018 Nov; 124(22):4383-4392. PubMed ID: 30329160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial.
    James RD; Glynne-Jones R; Meadows HM; Cunningham D; Myint AS; Saunders MP; Maughan T; McDonald A; Essapen S; Leslie M; Falk S; Wilson C; Gollins S; Begum R; Ledermann J; Kadalayil L; Sebag-Montefiore D
    Lancet Oncol; 2013 May; 14(6):516-24. PubMed ID: 23578724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definitive Pelvic Radiotherapy and Survival of Patients With Newly Diagnosed Metastatic Anal Cancer.
    Wang Y; Yu X; Zhao N; Wang J; Lin C; Izaguirre EW; Farmer M; Tian G; Somer B; Dubal N; Schwartz DL; Ballo MT; VanderWalde NA
    J Natl Compr Canc Netw; 2019 Jan; 17(1):29-37. PubMed ID: 30659127
    [No Abstract]   [Full Text] [Related]  

  • 16. Locally Advanced (T3-T4 or N+) Anal Cancer Treated with Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy.
    Franco P; Arcadipane F; Ragona R; Mistrangelo M; Cassoni P; Rondi N; Morino M; Racca P; Ricardi U
    Anticancer Res; 2016 Apr; 36(4):2027-32. PubMed ID: 27069197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Population-Based Cohort Analysis of Chemoradiation Versus Radiation Alone for Definitive Treatment of Stage I Anal Cancer in Older Patients.
    Buckstein M; Arens Y; Wisnivesky J; Gaisa M; Goldstone S; Sigel K
    Dis Colon Rectum; 2018 Jul; 61(7):787-794. PubMed ID: 29771796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoradiation versus local excision in treatment of stage I anal squamous cell carcinoma: A population-based analysis.
    Gao X; Goffredo P; Kahl AR; Charlton ME; Weigel RJ; Hassan I
    Eur J Surg Oncol; 2020 Sep; 46(9):1663-1667. PubMed ID: 32199768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nodal stage migration and prognosis in anal cancer: a systematic review, meta-regression, and simulation study.
    Sekhar H; Zwahlen M; Trelle S; Malcomson L; Kochhar R; Saunders MP; Sperrin M; van Herk M; Sebag-Montefiore D; Egger M; Renehan AG
    Lancet Oncol; 2017 Oct; 18(10):1348-1359. PubMed ID: 28802802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensity modulated radiotherapy in anal canal squamous cell carcinoma: Implementation and outcomes.
    Das A; Arunsingh M; Bhattacharyya T; Prasath SS; Balakrishnan A; Mallick I
    J Cancer Res Ther; 2021; 17(4):975-981. PubMed ID: 34528551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.